Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 198698, 10 pages
http://dx.doi.org/10.1155/2013/198698
Review Article

Anti-Müllerian Hormone and Its Clinical Use in Pediatrics with Special Emphasis on Disorders of Sex Development

1Department of Growth and Reproduction, GR, 5064 Rigshospitalet, Faculty of Medical and Health Sciences, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark
2INSERM U782 Research Unit and Paris Sud University, 92140 Clamart, France

Received 15 May 2013; Accepted 20 October 2013

Academic Editor: Petra Stute

Copyright © 2013 Marie Lindhardt Johansen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jost, “Hormonal factors in the sex differentiation of the mammalian foetus,” Philosophical transactions of the Royal Society of London. Series B, vol. 259, no. 828, pp. 119–130, 1970. View at Google Scholar · View at Scopus
  2. N. Josso, C. Racine, N. Di Clemente, R. R. Rodolfo Rey, and F. Xavier, “The role of anti-Müllerian hormone in gonadal development,” Molecular and Cellular Endocrinology, vol. 145, no. 1-2, pp. 3–7, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Rey and R. P. Grinspon, “Normal male sexual differentiation and aetiology of disorders of sex development,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 25, no. 2, pp. 221–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Y.-H. Lin, W.-C. Chiu, C.-H. Wu, C.-R. Tzeng, C.-S. Hsu, and M.-I. Hsu, “Anti-Müllerian hormone and polycystic ovary syndrome,” Fertility and Sterility, vol. 96, no. 1, pp. 230–235, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Jamieson and P. J. Fuller, “Molecular pathogenesis of granulosa cell tumors of the ovary,” Endocrine Reviews, vol. 33, no. 1, pp. 109–144, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Young, R. Rey, B. Couzinet, P. Chanson, N. Josso, and G. Schaison, “Anti-Müllerian hormone in patients with hypogonadotropic hypogonadism,” The Journal of Clinical Endocrinology & Metabolism, vol. 84, no. 8, pp. 2696–2699, 1999. View at Google Scholar · View at Scopus
  7. R. L. Cate, R. J. Mattaliano, and C. Hession, “Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells,” Cell, vol. 45, no. 5, pp. 685–698, 1986. View at Google Scholar · View at Scopus
  8. O. Cohen-Haguenauer, J. Y. Picard, and M.-G. Mattei, “Mapping of the gene for anti-Müllerian hormone to the short arm of human chromosome 19,” Cytogenetics and Cell Genetics, vol. 44, no. 1, pp. 2–6, 1987. View at Google Scholar · View at Scopus
  9. S. Imbeaud, E. Faure, I. Lamarre et al., “Insensitivity to anti-Müllerian hormone due to a mutation in the human anti-Müllerian hormone receptor,” Nature Genetics, vol. 11, no. 4, pp. 382–388, 1995. View at Google Scholar · View at Scopus
  10. N. Josso and N. Di Clemente, “Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-β family,” Trends in Endocrinology and Metabolism, vol. 14, no. 2, pp. 91–97, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. C. P. Hagen, L. Aksglaede, K. Sørensen et al., “Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 turner syndrome patients,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 11, pp. 5003–5010, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Aksglaede, K. Sørensen, M. Boas et al., “Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 12, pp. 5357–5364, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. C. P. Hagen, L. Aksglaede, K. Sørensen, A. Mouritsen, and A. Juul, “Clinical use of anti-Müllerian hormone (AMH) determinations in patients with disorders of sex development: importance of sex- and age-specific reference ranges,” Pediatric Endocrinology Reviews, vol. 9, pp. 525–528, 2011. View at Google Scholar · View at Scopus
  14. N. A. Arango, R. Lovell-Badge, and R. R. Behringer, “Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development,” Cell, vol. 99, no. 4, pp. 409–419, 1999. View at Google Scholar · View at Scopus
  15. A. Swain and R. Lovell-Badge, “Mammalian sex determination: a molecular drama,” Genes and Development, vol. 13, no. 7, pp. 755–767, 1999. View at Google Scholar · View at Scopus
  16. A. Jørgensen, J. E. Nielsen, M. B. Jensen, N. Graem, and E. Rajpert-de Meyts, “Analysis of meiosis regulators in human gonads: a sexually dimorphic spatio-temporal expression pattern suggests involvement of DMRT1 in meiotic entry,” Molecular Human Reproduction, vol. 18, pp. 523–534, 2012. View at Google Scholar
  17. R. Rey, I. Lordereau-Richard, J.-C. Carel et al., “Anti-Müllerian hormone and testosterone serum levels are inversely related during normal and precocious pubertal development,” The Journal of Clinical Endocrinology & Metabolism, vol. 77, no. 5, pp. 1220–1226, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. Lee, P. K. Donahoe, T. Hasegawa et al., “Müllerian inhibiting substance in humans: normal levels from infancy to adulthood,” The Journal of Clinical Endocrinology & Metabolism, vol. 81, no. 2, pp. 571–576, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. M. L. Baker and J. M. Hutson, “Serum levels of Müllerian inhibiting substance in boys throughout puberty and in the first two years of life,” The Journal of Clinical Endocrinology & Metabolism, vol. 76, no. 1, pp. 245–247, 1993. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Steger, R. Rey, S. Kliesch, F. Louis, G. Schleicher, and M. Bergmann, “Immunohistochemical detection of immature Sertoli cell markers in testicular tissue of infertile adult men: a preliminary study,” International Journal of Andrology, vol. 19, no. 2, pp. 122–128, 1996. View at Google Scholar · View at Scopus
  21. E. Rajpert-de Meyts, N. Jørgensen, N. Græm, J. Müller, R. L. Cate, and N. E. Skakkebæk, “Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells,” The Journal of Clinical Endocrinology & Metabolism, vol. 84, no. 10, pp. 3836–3844, 1999. View at Google Scholar · View at Scopus
  22. R. P. Grinspon, N. Loreti, D. Braslavsky et al., “Sertoli cell markers in the diagnosis of paediatric male hypogonadism,” Journal of Pediatric Endocrinology and Metabolism, vol. 25, no. 1-2, pp. 3–11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. R. P. Grinspon and R. A. Rey, “Anti-Müllerian hormone and sertoli cell function in paediatric male hypogonadism,” Hormone Research in Paediatrics, vol. 73, no. 2, pp. 81–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Lukas-Croisier, C. Lasala, J. Nicaud et al., “Follicle-stimulating hormone increases testicular anti-Müllerian hormone (AMH) production through Sertoli cell proliferation and a nonclassical cyclic adenosine 5′-monophosphate-mediated activation of the AMH gene,” Molecular Endocrinology, vol. 17, no. 4, pp. 550–561, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Boukari, G. Meduri, S. Brailly-Tabard et al., “Lack of androgen receptor expression in sertoli cells accounts for the absence of anti-Müllerian hormone repression during early human testis development,” The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 5, pp. 1818–1825, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Jegou, “The Sertoli-germ cell communication network in mammals,” International Review of Cytology, vol. 147, pp. 25–96, 1993. View at Google Scholar · View at Scopus
  27. R. Rey, L. Al-Attar, F. Louis et al., “Testicular dysgenesis does not affect expression of anti-Müllerian hormone by sertoli cells in premeiotic seminiferous tubules,” American Journal of Pathology, vol. 148, no. 5, pp. 1689–1698, 1996. View at Google Scholar · View at Scopus
  28. R. Rey, “Endocrine, paracrine and cellular regulation of postnatal anti-Müllerian hormone secretion by Sertoli cells,” Trends in Endocrinology and Metabolism, vol. 9, no. 7, pp. 271–276, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Bezard, B. Vigier, D. Tran, P. Mauleon, and N. Josso, “Anti-Müllerian hormone in sheep follicles,” Reproduction Nutrition Developpement, vol. 28, no. 4 B, pp. 1105–1112, 1988. View at Google Scholar · View at Scopus
  30. C. Weenen, J. S. E. Laven, A. R. M. von Bergh et al., “Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment,” Molecular Human Reproduction, vol. 10, no. 2, pp. 77–83, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. J. V. Jeppesen, R. A. Anderson, T. W. Kelsey et al., “Which follicles make the most anti-Müllerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection,” Molecular Human Reproduction, vol. 19, no. 8, pp. 519–527, 2013. View at Publisher · View at Google Scholar
  32. K. R. Hansen, G. M. Hodnett, N. Knowlton, and L. B. Craig, “Correlation of ovarian reserve tests with histologically determined primordial follicle number,” Fertility and Sterility, vol. 95, no. 1, pp. 170–175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. C. P. Hagen, L. Aksglaede, K. Sørensen et al., “Individual serum levels of anti-Mllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study,” Human Reproduction, vol. 27, no. 3, pp. 861–866, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Lashen, D. B. Dunger, A. Ness, and K. K. Ong, “Peripubertal changes in circulating anti-Müllerian hormone levels in girls,” Fertility and Sterility, vol. 99, no. 7, pp. 2071–2075, 2013. View at Publisher · View at Google Scholar
  35. W. H. B. Wallace and T. W. Kelsey, “Human ovarian reserve from conception to the menopause,” PloS ONE, vol. 5, no. 1, Article ID e8772, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. La Marca, F. J. Broekmans, A. Volpe, B. C. Fauser, and N. S. MacKlon, “Anti-Müllerian hormone (AMH): what do we still need to know?” Human Reproduction, vol. 24, no. 9, pp. 2264–2275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Di Clemente, C. Wilson, E. Faure et al., “Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone,” Molecular Endocrinology, vol. 8, no. 8, pp. 1006–1020, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. M. P. Grossman, S. T. Nakajima, M. E. Fallat, and Y. Siow, “Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture,” Fertility and Sterility, vol. 89, no. 5, pp. 1364–1370, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. E. Nielsen, I. A. Rasmussen, S. G. Kristensen et al., “In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA,” Molecular Human Reproduction, vol. 17, no. 1, Article ID gaq073, pp. 63–70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. S. M. Nelson and A. La Marca, “The journey from the old to the new AMH assay: how to avoid getting lost in the values,” Reproductive BioMedicine Online, vol. 23, no. 4, pp. 411–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Kumar, B. Kalra, A. Patel, L. McDavid, and W. E. Roudebush, “Development of a second generation anti-Müllerian hormone (AMH) ELISA,” Journal of Immunological Methods, vol. 362, no. 1-2, pp. 51–59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. H. W. Li, E. H. Ng, B. P. Wong, R. A. Anderson, P. C. Ho, and W. S. Yeung, “Correlation between three assay systems for anti-Müllerian hormone (AMH) determination,” Journal of Assisted Reproduction and Genetics, vol. 29, pp. 1443–1446, 2012. View at Google Scholar
  43. F. S. Lie, J. A. Visser, C. K. Welt et al., “Serum anti-Müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, pp. 4650–4655, 2012. View at Google Scholar
  44. R. Fleming and S. M. Nelson, “Reproducibility of AMH,” Human Reproduction, vol. 27, pp. 3639–3641, 2012. View at Google Scholar
  45. A. M. Wallace, S. A. Faye, R. Fleming, and S. M. Nelson, “A multicentre evaluation of the new Beckman Coulter anti-Müllerian hormone immunoassay (AMH Gen II),” Annals of Clinical Biochemistry, vol. 48, no. 4, pp. 370–373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. W. J. K. Hehenkamp, C. W. N. Looman, A. P. N. Themmen, F. H. De Jong, E. R. Te Velde, and F. J. M. Broekmans, “Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 10, pp. 4057–4063, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. T. W. Kelsey, P. Wright, S. M. Nelson, R. A. Anderson, and W. H. B. Wallace, “A validated model of serum Anti-Müllerian hormone from conception to menopause,” PLoS ONE, vol. 6, no. 7, Article ID e22024, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. M. M. Lee, P. K. Donahoe, B. L. Silverman et al., “Measurements of serum Müllerian inhibiting substance in the evaluation of children with nonpalpable gonads,” The New England Journal of Medicine, vol. 336, no. 21, pp. 1480–1486, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Stoppa-Vaucher, A. Djemli, and G. Van Vliet, “Undetectable AMH at 3days of age: a clue to bilateral anorchia,” Clinical Biochemistry, vol. 43, no. 16-17, pp. 1373–1374, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Misra, D. T. MacLaughlin, P. K. Donahoe, M. M. Lee, and M. Massachusetts, “Measurement of Müllerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism,” The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 8, pp. 3598–3602, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. R. P. Grinspon and R. A. Rey, “New perspectives in the diagnosis of pediatric male hypogonadism: the importance of AMH as a sertoli cell marker,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 55, no. 8, pp. 512–519, 2011. View at Google Scholar · View at Scopus
  52. R. Brauner, M. Neve, S. Allali et al., “Clinical, biological and genetic analysis of anorchia in 26 boys,” PLoS ONE, vol. 6, no. 8, Article ID e23292, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Guibourdenche, N. Lucidarme, D. Chevenne et al., “Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest,” Molecular and Cellular Endocrinology, vol. 211, no. 1-2, pp. 55–63, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. M. L. Gustafson, M. M. Lee, L. Asmundson, D. T. MacLaughlin, P. K. Donahoe, and A. Pena, “Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities,” Journal of Pediatric Surgery, vol. 28, no. 3, pp. 439–444, 1993. View at Publisher · View at Google Scholar · View at Scopus
  55. M. M. Lee, M. Misra, P. K. Donahoe, and D. T. MacLaughlin, “MIS/AMH in the assessment of cryptorchidism and intersex conditions,” Molecular and Cellular Endocrinology, vol. 211, no. 1-2, pp. 91–98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. F. H. Pierik, J. A. Deddens, A. Burdorf, S. M. P. F. D. M. Keizer-Schrama, F. H. D. Jong, and R. F. A. Weber, “The hypothalamus-pituitary-testis axis in boys during the first six months of life: a comparison of cryptorchidism and hypospadias cases with controls,” International Journal of Andrology, vol. 32, no. 5, pp. 453–461, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. N. Josso, R. Rey, and J. Y. Picard, “Testicular anti-Müllerian hormone: clinical applications in DSD,” Seminars in Reproductive Medicine, vol. 30, pp. 364–373, 2012. View at Google Scholar
  58. C. Belville, H. Van Vlijmen, C. Ehrenfels et al., “Mutations of the anti-Müllerian hormone gene in patients with persistent Müllerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model,” Molecular Endocrinology, vol. 18, no. 3, pp. 708–721, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. N. Josso, C. Belville, N. di Clemente, and J.-Y. Picard, “AMH and AMH receptor defects in persistent Müllerian duct syndrome,” Human Reproduction Update, vol. 11, no. 4, pp. 351–356, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Guerrier, D. Tran, J. M. Vanderwinden et al., “The persistent Müllerian duct syndrome: a molecular approach,” The Journal of Clinical Endocrinology & Metabolism, vol. 68, no. 1, pp. 46–52, 1989. View at Google Scholar · View at Scopus
  61. M. Misra, D. T. MacLaughlin, P. K. Donahoe, and M. M. Lee, “The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 2, pp. 787–792, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. C. P. Hagen, K. M. Main, S. Kjaergaard, and A. Juul, “FSH, LH, inhibin B and estradiol levels in Turner syndrome depend on age and karyotype: longitudinal study of 70 Turner girls with or without spontaneous puberty,” Human Reproduction, vol. 25, no. 12, pp. 3134–3141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. J. A. Visser, A. C. Hokken-Koelega, G. R. Zandwijken, A. Limacher, M. B. Ranke, and C. E. Fluck, “Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment,” Human Reproduction, vol. 28, no. 7, pp. 1899–1907, 2013. View at Publisher · View at Google Scholar
  64. M. F. Brougham, P. M. Crofton, E. J. Johnson, N. Evans, R. A. Anderson, and W. H. Wallace, “Anti-Müllerian hormone is a marker of gonadotoxicity in pre- and postpubertal girls treated for cancer: a prospective study,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, pp. 2059–2067, 2012. View at Google Scholar
  65. L. Adan, P. Lechevalier, A.-C. Couto-Silva et al., “Plasma inhibin B and anti-Müllerian hormone concentrations in boys: discriminating between congenital hypogonadotropic hypogonadism and constitutional pubertal delay,” Case Reports and Clinical Practice Review, vol. 16, no. 11, pp. CR511–CR517, 2010. View at Google Scholar · View at Scopus
  66. M. Hero, J. Tommiska, K. Vaaralahti et al., “Circulating anti-Müllerian hormone levels in boys decline during early puberty and correlate with inhibin B,” Fertility and Sterility, vol. 97, no. 5, pp. 1242–1247, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Young, R. Rey, G. Schaison, and P. Chanson, “Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans,” Molecular and Cellular Endocrinology, vol. 211, no. 1-2, pp. 51–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Coutant, E. Biette-Demeneix, C. Bouvattier et al., “Baseline inhibin B and anti-Müllerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 12, pp. 5225–5232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. C. P. Hagen, K. Sorensen, R. A. Anderson, and A. Juul, “Serum levels of anti-Müllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist,” Fertility and Sterility, vol. 98, pp. 1326–1330, 2012. View at Google Scholar
  70. M. Sönmezer, B. Özmen, C. S. Atabekoglu et al., “Serum anti-Müllerian hormone levels correlate with ovarian response in idiopathic hypogonadotropic hypogonadism,” Journal of Assisted Reproduction and Genetics, pp. 1–6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. L. Aksglaede, P. Christiansen, K. Sørensen et al., “Serum concentrations of Anti-Müllerian Hormone (AMH) in 95 patients with Klinefelter syndrome with or without cryptorchidism,” Acta Paediatrica, vol. 100, no. 6, pp. 839–845, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. M. G. Bastida, R. A. Rey, I. Bergadá et al., “Establishment of testicular endocrine function impairment during childhood and puberty in boys with Klinefelter syndrome,” Clinical Endocrinology, vol. 67, no. 6, pp. 863–870, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. N. Lahlou, I. Fennoy, J.-C. Carel, and M. Roger, “Inhibin B and anti-Müllerian hormone, but not testosterone levels, are normal in infants with nonmosaic klinefelter syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 4, pp. 1864–1868, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. N. Pacenza, T. Pasqualini, S. Gottlieb et al., “Clinical presentation of Klinefelter's syndrome: differences according to age,” International Journal of Endocrinology, vol. 2012, Article ID 324835, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. R. A. Rey, S. Gottlieb, T. Pasqualini et al., “Are Klinefelter boys hypogonadal?” Acta Paediatrica, vol. 100, no. 6, pp. 830–838, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. A. M. Wikström, T. Raivio, F. Hadziselimovic, S. Wikström, T. Tuuri, and L. Dunkel, “Klinefelter syndrome in adolescence: onset of puberty is associated with accelerated germ cell depletion,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 5, pp. 2263–2270, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Ali, P. Gattuso, A. Howard, M. B. Mosunjac, and M. T. Siddiqui, “Adult granulosa cell tumor of the ovary: fine-needle-aspiration cytology of 10 cases and review of literature,” Diagnostic Cytopathology, vol. 36, no. 5, pp. 297–302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. R. Kanthan, J. L. Senger, and S. Kanthan, “The multifaceted granulosa cell tumours—myths and realities: a review,” ISRN Obstetrics and Gynecology, vol. 2012, Article ID 878635, 12 pages, 2012. View at Publisher · View at Google Scholar
  79. N. Colombo, G. Parma, V. Zanagnolo, and A. Insinga, “Management of ovarian stromal cell tumors,” Journal of Clinical Oncology, vol. 25, no. 20, pp. 2944–2951, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. S. T. Schumer and S. A. Cannistra, “Granulosa cell tumor of the ovary,” Journal of Clinical Oncology, vol. 21, no. 6, pp. 1180–1189, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Ashnagar, S. Alavi, Y. Nilipour, R. Azma, and F. Falahati, “Massive ascites as the only sign of ovarian juvenile granulosa cell tumor in an adolescent: a case report and a review of the literature,” Case Reports in Oncological Medicine, vol. 2013, Article ID 386725, 4 pages, 2013. View at Publisher · View at Google Scholar
  82. A. La Marca and A. Volpe, “The anti-Müllerian hormone and ovarian cancer,” Human Reproduction Update, vol. 13, no. 3, pp. 265–273, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. L. A. Silverman and S. E. Gitelman, “Immunoreactive inhibin, Müllerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumors,” Journal of Pediatrics, vol. 129, no. 6, pp. 918–921, 1996. View at Google Scholar · View at Scopus
  84. M. L. Gustafson, M. M. Lee, R. E. Scully et al., “Müllerian inhibiting substance as a marker for ovarian sex-cord tumor,” The New England Journal of Medicine, vol. 326, no. 7, pp. 466–471, 1992. View at Google Scholar · View at Scopus
  85. R. A. Rey, C. Lhomme, I. Marcillac et al., “Anti-Müllerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum α-inhibin and estradiol,” American Journal of Obstetrics and Gynecology, vol. 174, no. 3, pp. 958–965, 1996. View at Publisher · View at Google Scholar · View at Scopus
  86. A. H. Lane, M. M. Lee, A. F. Fuller Jr., D. J. Kehas, P. K. Donahoe, and D. T. MacLaughlin, “Diagnostic utility of Müllerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors,” Gynecologic Oncology, vol. 73, no. 1, pp. 51–55, 1999. View at Publisher · View at Google Scholar · View at Scopus
  87. W.-Q. Long, V. Ranchin, P. Pautier et al., “Detection of minimal levels of serum anti-Müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay,” The Journal of Clinical Endocrinology & Metabolism, vol. 85, no. 2, pp. 540–544, 2000. View at Publisher · View at Google Scholar · View at Scopus
  88. H. L. Chang, N. Pahlavan, E. F. Halpern, and D. T. MacLaughlin, “Serum Müllerian inhibiting substance/anti-Müllerian Hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology,” Gynecologic Oncology, vol. 114, no. 1, pp. 57–60, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. L. E. Puls, J. Hamous, M. S. Morrow, A. Schneyer, D. T. MacLaughlin, and V. D. Castracane, “Recurrent ovarian sex cord tumor with annular tubules: tumor marker and chemotherapy experience,” Gynecologic Oncology, vol. 54, no. 3, pp. 396–401, 1994. View at Publisher · View at Google Scholar · View at Scopus
  90. R. Rey, J.-C. Sabourin, M. Venara et al., “Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors,” Human Pathology, vol. 31, no. 10, pp. 1202–1208, 2000. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Anttonen, L. Unkila-Kallio, A. Leminen, R. Butzow, and M. Heikinheimo, “High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors,” The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 12, pp. 6529–6535, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. T. Sir-Petermann, E. Codner, M. Maliqueo et al., “Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 8, pp. 3105–3109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. P. Pigny, E. Merlen, Y. Robert et al., “Elevated serum level of anti-Müllerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 12, pp. 5957–5962, 2003. View at Publisher · View at Google Scholar · View at Scopus
  94. J. S. E. Laven, A. G. M. G. J. Mulders, J. A. Visser, A. P. Themmen, F. H. De Jong, and B. C. J. M. Fauser, “Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 1, pp. 318–323, 2004. View at Publisher · View at Google Scholar · View at Scopus
  95. D. Dewailly, H. Gronier, E. Poncelet et al., “Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries,” Human Reproduction, vol. 26, no. 11, pp. 3123–3129, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. R. Hart, D. A. Doherty, R. J. Norman et al., “Serum anti-Müllerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS),” Fertility and Sterility, vol. 94, no. 3, pp. 1118–1121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. L. Li, X. Chen, Y. Mo, Y. Chen, M. Wenig, and D. Yang, “Elevated serum anti-Müllerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome,” Wiener Klinische Wochenschrift, vol. 122, no. 17-18, pp. 519–524, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. P. Pigny, S. Jonard, Y. Robert, and D. Dewailly, “Serum anti-Müllerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 3, pp. 941–945, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. L. Casadei, A. Madrigale, F. Puca et al., “The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome,” Gynecological Endocrinology, vol. 29, no. 6, pp. 545–550, 2013. View at Publisher · View at Google Scholar
  100. D. Apter, L. Viinikka, and R. Vihko, “Hormonal pattern of adolescent menstrual cycles,” The Journal of Clinical Endocrinology & Metabolism, vol. 47, no. 5, pp. 944–954, 1978. View at Google Scholar · View at Scopus
  101. F. Rigon, V. De Sanctis, S. Bernasconi et al., “Menstrual pattern and menstrual disorders among adolescents: an update of the Italian data,” Italian Journal of Pediatrics, vol. 38, p. 38, 2012. View at Publisher · View at Google Scholar
  102. R. F. Vollman, “The menstrual cycle,” Major Problems in Obstetrics and Gynecology, vol. 7, pp. 1–193, 1977. View at Google Scholar · View at Scopus
  103. M. Pawelczak, L. Kenigsberg, S. Milla, Y. H. Liu, and B. Shah, “Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features,” Journal of Pediatric Endocrinology and Metabolism, vol. 25, pp. 983–989, 2012. View at Google Scholar
  104. A. S. Park, M. A. Lawson, S. S. Chuan et al., “Serum anti-Müllerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 4, pp. 1786–1792, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. J. G. Bentzen, J. L. Forman, A. Pinborg et al., “Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception,” Reproductive BioMedicine Online, vol. 25, pp. 612–619, 2012. View at Google Scholar
  106. E. Arbo, D. V. Vetori, M. F. Jimenez, F. M. Freitas, N. Lemos, and J. S. Cunha-Filho, “Serum anti-Müllerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills,” Human Reproduction, vol. 22, no. 12, pp. 3192–3196, 2007. View at Publisher · View at Google Scholar · View at Scopus